Plasmapheresis treatment in patients with severe atopic keratoconjunctivitis.
A 19-year-old woman with hyperimmunoglobulinemia E (the hyper-IgE syndrome [HIE]) and a 62-year-old man with atopic dermatitis experienced dramatic improvement in their chronic ocular symptoms and signs of atopic keratoconjunctivitis after plasmapheresis was instituted. Both patients had previously received topical and oral corticosteroids as well as topical cromolyn sodium without significant beneficial effect. The authors recommend a trial of plasmapheresis in selected patients with recalcitrant and debilitating atopic keratoconjunctivitis when standard therapy proves unsuccessful.
Aswad
M I
MI
Department of Ophthalmology, New England Medical Center, Boston, MA 02111.
Tauber
J
J
Baum
J
J
D000328:Adult; D003876:Dermatitis, Atopic / Q000150:complications / Q000473:pathology / Q000628:therapy; D005260:Female; D006801:Humans; D006942:Hypergammaglobulinemia / Q000150:complications* / Q000628:therapy; D006967:Hypersensitivity / Q000150:complications* / Q000628:therapy; D007074:Immunoglobulin G; D007634:Keratitis / Q000209:etiology / Q000473:pathology; D007637:Keratoconjunctivitis / Q000150:complications / Q000209:etiology* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010956:Plasmapheresis; D013203:Staphylococcal Infections / Q000150:complications; D013577:Syndrome
D007074:Immunoglobulin G